ADMA
ADMA Biologics Inc
9.70$
-2.1%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 78.0 | 71.9 | 21.4 | 23.4 | 21.7 | 17.2 | 30.2 | 13.1 | 11.5 | |
| 9.4 | 6.2 | 5.7 | 4.9 | 5.7 | 6.4 | 8.6 | 7.6 | 11.5 | 6.5 | 10.7 | 11.1 | 12.5 | 8.1 | 5.9 | 6.7 | 5.2 | 4.6 | 4.3 | 3.5 | 2.1 | 3.1 | 3.8 | 3.6 | 3.6 | 5.1 | 4.0 | 4.0 | 3.6 | 3.9 | 5.5 | 8.2 | 12.8 | 9.9 | 10.5 | 9.5 | 7.4 | 8.7 | 4.2 | 3.8 | |
| – | – | – | 2.2 | 6.2 | 3.6 | 9.1 | 3.7 | 7.7 | 5.6 | 17.5 | 4.3 | 7.4 | 9.1 | 2.2 | 3.3 | 2.9 | 2.2 | 1.9 | 1.8 | 1.4 | 1.8 | 2.8 | 3.4 | 4.7 | 5.2 | 5.0 | 5.6 | 5.6 | 7.5 | 10.2 | 14.4 | 21.1 | 12.1 | 13.0 | 11.4 | 8.3 | 9.3 | 5.5 | 4.7 | |
| 10.5 | 7.0 | 6.5 | 4.3 | 6.1 | 5.9 | 10.4 | 6.5 | 11.0 | 6.9 | 12.2 | 11.6 | 14.1 | 9.5 | 5.8 | 7.3 | 6.2 | 5.5 | 5.0 | 4.4 | 3.0 | 3.7 | 4.5 | 4.4 | 4.4 | 5.5 | 4.4 | 4.3 | 3.9 | 4.2 | 5.8 | 8.3 | 12.8 | 9.8 | 10.6 | 9.5 | 7.4 | 8.7 | 4.4 | 3.9 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 92.1 | 214.3 | 58.7 | 40.7 | 49.7 | 28.4 | 30.1 | 27.6 | 21.0 | 22.4 | 10.0 | 8.5 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 252.5 | 96.7 | 40.7 | 61.7 | 38.3 | 53.5 | 68.8 | 88.3 | 159.5 | 20.0 | 16.6 | |
| -20.3% | -27.9% | -29.4% | -37.2% | -35.3% | -27.5% | -24.7% | -30.2% | -21.1% | -58.2% | -35.3% | -32.2% | -29.4% | -33.7% | -43.2% | -39.5% | -47.6% | -59.4% | -59.5% | -66.3% | -84.6% | -49.7% | -33.7% | -25.2% | -21.1% | -9.3% | -8.4% | -6.2% | -2.8% | 0.4% | 1.0% | 2.5% | 1.6% | 2.6% | 1.9% | 1.5% | 1.1% | 0.6% | 5.0% | 6.0% | |
| Margins | ||||||||||||||||||||||||||||||||||||||||
| 40.6% | 40.3% | 39.9% | 21.1% | -36.7% | -28.1% | -64.6% | -77.4% | -72.4% | -148.4% | -138.9% | -118.8% | -82.3% | -34.6% | -30.3% | -34.1% | -33.7% | -45.2% | -29.5% | -16.3% | -10.9% | 1.4% | 7.0% | 13.9% | 18.9% | 22.9% | 26.5% | 27.4% | 30.7% | 34.4% | 39.4% | 46.1% | 48.9% | 51.5% | 52.6% | 53.0% | 54.7% | 57.4% | 61.3% | 64.7% | |
| -177.9% | -162.6% | -171.1% | -179.1% | -232.2% | -172.7% | -206.4% | -216.0% | -217.7% | -354.9% | -345.8% | -298.7% | -234.7% | -141.1% | -124.9% | -136.3% | -137.8% | -153.8% | -131.7% | -106.3% | -91.1% | -72.1% | -61.7% | -46.9% | -35.6% | -25.5% | -13.9% | -8.0% | 0.6% | 8.4% | 15.6% | 25.4% | 30.0% | 32.6% | 33.1% | 32.8% | 34.2% | 37.5% | 40.6% | 42.3% | |
| -198.4% | -183.1% | -192.0% | -199.0% | -250.9% | -192.3% | -227.7% | -238.9% | -243.4% | -387.1% | -370.3% | -323.5% | -260.9% | -164.5% | -151.2% | -164.9% | -166.0% | -179.4% | -155.8% | -126.7% | -108.6% | -88.5% | -83.3% | -66.4% | -53.9% | -42.8% | -26.2% | -19.4% | -9.7% | -10.9% | -1.3% | 10.5% | 17.8% | 46.4% | 45.0% | 44.1% | 42.9% | 28.8% | 32.4% | 33.0% | |
| -190.9% | -172.1% | -166.2% | -183.7% | -200.2% | -175.5% | -213.2% | -228.3% | -242.8% | -381.4% | -377.5% | -356.7% | -366.8% | -272.6% | -256.3% | -265.9% | -248.5% | -271.7% | -257.6% | -232.5% | -181.8% | -155.5% | -126.5% | -89.9% | -76.2% | -47.7% | -33.7% | -24.7% | -10.0% | 1.6% | 5.7% | 20.2% | 20.7% | 25.9% | 19.7% | 13.9% | 8.3% | 5.5% | 21.2% | 22.7% | |
| Returns | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | -88.4% | -272.0% | -108.5% | -239.1% | -117.4% | -163.1% | -332.5% | -607.5% | -126.8% | -154.4% | -184.3% | -56.5% | -79.9% | -93.7% | -85.8% | -66.6% | -66.0% | -72.4% | -50.8% | -61.7% | -63.9% | -70.1% | -43.4% | -32.7% | -27.5% | -15.1% | -20.9% | -2.4% | 18.5% | 29.4% | 56.6% | 55.4% | 52.5% | 48.6% | 30.8% | 42.4% | 41.4% | |
| -71.1% | -82.4% | -121.9% | -28.9% | -48.5% | -40.5% | -60.4% | -51.6% | -57.1% | -74.0% | -78.1% | -41.5% | -40.5% | -38.0% | -25.9% | -32.1% | -35.2% | -36.5% | -31.8% | -31.6% | -31.2% | -25.9% | -25.4% | -24.6% | -23.4% | -18.9% | -14.0% | -11.7% | -6.5% | -8.6% | -1.0% | 9.2% | 17.4% | 40.5% | 40.5% | 37.4% | 36.8% | 23.5% | 24.9% | 24.7% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||||||||||||
| 10 | 8.5 | 9.0 | -7.8 | 6.6 | -12 | 43 | -26 | -13 | 6.5 | 25 | 9.0 | 35 | 42 | -4.9 | 21 | 38 | 37 | 32 | 52 | 60 | 44 | 70 | 88 | 107 | 57 | 76 | 79 | 69 | 80 | 87 | 44 | 16 | -30 | 2.1 | -16 | 12 | -14 | 60 | 62 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 7.0 | 15.7 | 3.1 | 0.6 | 0.2 | -0.2 | 0.0 | -0.1 | 0.1 | -0.1 | 0.3 | 0.3 | |
| -0.6% | -18.8% | -61.1% | 32.7% | 17.8% | 37.3% | 25.3% | 44.0% | 35.0% | 22.2% | 12.9% | 32.7% | 26.2% | 20.6% | 45.8% | 40.1% | 37.6% | 42.5% | 47.7% | 47.9% | 43.1% | 51.1% | 41.2% | 38.5% | 33.4% | 43.6% | 42.7% | 42.8% | 43.4% | 41.1% | 43.8% | 50.0% | 59.4% | 71.4% | 73.1% | 71.3% | 75.8% | 76.5% | 58.7% | 59.7% | |
| – | – | – | 0.6 | 1.6 | 0.8 | 3.0 | 0.6 | 0.8 | 1.5 | 4.1 | 1.8 | 2.3 | 2.6 | 1.0 | 1.3 | 1.4 | 1.1 | 0.8 | 0.8 | 0.9 | 0.7 | 1.1 | 1.2 | 1.4 | 0.9 | 1.0 | 1.0 | 0.9 | 1.0 | 0.9 | 0.7 | 0.4 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.5 | 0.5 | |
| Per Share | ||||||||||||||||||||||||||||||||||||||||
| -1.52 | -1.51 | -1.66 | -1.49 | -1.37 | -0.97 | -1.21 | -1.42 | -1.31 | -1.42 | -1.32 | -1.14 | -0.94 | -0.81 | -0.74 | -0.71 | -0.76 | -0.78 | -0.65 | -0.58 | -0.56 | -0.40 | -0.40 | -0.37 | -0.36 | -0.32 | -0.21 | -0.18 | -0.10 | -0.12 | -0.02 | 0.14 | 0.28 | 0.80 | 0.85 | 0.84 | 0.86 | 0.60 | 0.69 | 0.73 | |
| 0.76 | 0.83 | 0.87 | 0.75 | 0.55 | 0.50 | 0.53 | 0.60 | 0.54 | 0.37 | 0.36 | 0.35 | 0.36 | 0.49 | 0.49 | 0.43 | 0.46 | 0.44 | 0.42 | 0.46 | 0.51 | 0.45 | 0.48 | 0.56 | 0.66 | 0.76 | 0.82 | 0.93 | 1.00 | 1.14 | 1.20 | 1.36 | 1.56 | 1.73 | 1.88 | 1.91 | 2.00 | 2.09 | 2.12 | 2.22 | |
| -0.01 | -0.35 | -0.83 | 1.69 | 0.50 | 0.89 | 0.51 | 1.21 | 0.80 | 0.43 | 0.22 | 0.90 | 0.61 | 0.44 | 1.31 | 0.89 | 0.81 | 0.91 | 0.97 | 0.88 | 0.77 | 0.78 | 0.65 | 0.58 | 0.51 | 0.75 | 0.66 | 0.66 | 0.65 | 0.60 | 0.65 | 0.78 | 0.95 | 1.42 | 1.53 | 1.60 | 1.76 | 1.96 | 1.63 | 1.77 | |
| -1.46 | -1.42 | -1.44 | -1.37 | -1.09 | -0.88 | -1.14 | -1.36 | -1.31 | -1.40 | -1.34 | -1.26 | -1.32 | -1.35 | -1.25 | -1.15 | -1.14 | -1.19 | -1.07 | -1.06 | -0.93 | -0.70 | -0.61 | -0.50 | -0.51 | -0.36 | -0.28 | -0.23 | -0.10 | 0.02 | 0.07 | 0.28 | 0.32 | 0.45 | 0.37 | 0.26 | 0.17 | 0.11 | 0.45 | 0.51 | |
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.